Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11771687 Substituted diazaspiroalkanes as androgen receptor modulators

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 4 Oct, 2023
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 4 Oct, 2023
Edits made to:
Infobox (+23 properties)
‌

 US Patent 11771687 Substituted diazaspiroalkanes as androgen receptor modulators

Infobox
Is a
Patent
Patent
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11771687
Patent Inventor Names
Charles L. Sawyers
Chris Tran
John Wongvipat
Michael E. Jung
Samedy Ouk
Date of Patent
October 3, 2023
Patent Application Number
17093047
Date Filed
November 9, 2020
Patent Citations
‌
US Patent 7271188 Imidazolidine derivatives
‌
US Patent 7709517 Diarylhydantoin compounds
‌
US Patent 8183274 Treatment of hyperproliferative disorders with diarylhydantoin compounds
‌
US Patent 8445507 Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases
‌
US Patent 8802689 Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases
‌
US Patent 9126941 Treatment of hyperproliferative disorders with diarylhydantoin compounds
‌
US Patent 9388159 Substituted diazaspiroalkanes as androgen receptor modulators
‌
US Patent 9987261 Substituted diazaspiroalkanes as androgen receptor modulators
‌
US Patent 10857139 Substituted diazaspiroalkanes as androgen receptor modulators
Patent Primary Examiner
‌
Douglas M Willis
CPC Code
‌
A61K 31/4439
‌
A61K 31/416

Find more entities like US Patent 11771687 Substituted diazaspiroalkanes as androgen receptor modulators

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.